Guidance

Human papillomavirus (HPV) vaccine for GBMSM: PGD template

Patient group direction (PGD) template to support the provision of HPV vaccine to gay, bisexual, and men who have sex with men (GBMSM).

• From: UK Health Security Agency
• Published: 11 April 2018
• Last updated: 16 August 2023 — See all updates

Applies to England

Documents

Human papillomavirus (HPV) vaccine, for GBMSM: PGD template

Ref: GOV-14793

MS Word Document, 141 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template supports the administration of HPV vaccine to GBMSM aged 45 years and under who attend Specialist Sexual Health Services (SSHS) and/or HIV clinics.

The HPV (GBMSM) PGD version 4.00a is valid from 1 September 2023 to 1 September 2025.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy/procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Published 11 April 2018
Last updated 16 August 2023 + show all updates

1. 16 August 2023

   Added version 4.00a; see page 3 for change history.

2. 7 July 2023

   Added version 4 – see page 3 for change history.

3. 8 March 2022

   Added version 3 – see page 2 for change history.

4. 3 March 2020

   Added V2.00 following routine review.

5. 11 April 2018

   First published.